Program: Education Program
Session: Hematologic Management of the Patient with Heavy Menstrual Bleeding
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Education, Diseases, Study Population, Human
Session: Hematologic Management of the Patient with Heavy Menstrual Bleeding
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Education, Diseases, Study Population, Human
Saturday, December 7, 2024, 2:00 PM-3:15 PM
Disclosures: Staber: Bayer: Membership on an entity's Board of Directors or advisory committees; BioMarin: Membership on an entity's Board of Directors or advisory committees; Sanofi: Membership on an entity's Board of Directors or advisory committees.
See more of: Hematologic Management of the Patient with Heavy Menstrual Bleeding
See more of: Education Program
See more of: Education Program
<< Previous Presentation
|
Next Presentation